Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term effects of sitagliptin on incretin hormones in type 2 diabetes
2006-002950-32Phase 2Completed
- Sponsor
- Gentofte Hospital
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Gentofte Hospital. Primary endpoint: Relative increase in meal-induced total GLP-1 secretion at 1 and 12 weeks. Started Oct 2006; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-002950-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002950-32.